Jennifer L. Brogdon
- Immunology top 1%
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 8
- Biosimilars and Bioanalytical Methods 3
- Oncology top 1%
- CAR-T cell therapy research 14
- Genetics top 5%
- Molecular Biology top 10%
- Signaling Pathways in Disease 3
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Asthma and respiratory diseases 3
- Co-authors
- Kim BottomlyDeborah KneeGlenn DranoffSimon F. LaceyJ. Joseph MelenhorstCarl H. JuneBruce L. LevineDavid L. Porter
- Cited by
- ImmunologyOncologyGenetics
- Journals
- Nature (1 paper)New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Jennifer L. Brogdon
30 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 1.6k
- Oncology 2.1k
- Genetics 418
- Pathology and Forensic Medicine 252
- Molecular Biology 785
Countries citing papers authored by Jennifer L. Brogdon
This map shows the geographic impact of Jennifer L. Brogdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer L. Brogdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer L. Brogdon more than expected).
Fields of papers citing papers by Jennifer L. Brogdon
This network shows the impact of papers produced by Jennifer L. Brogdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer L. Brogdon. The network helps show where Jennifer L. Brogdon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jennifer L. Brogdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 7 | |
| 3 | 2021 | 19 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 31 | |
| 7 | 2020 | 4 | |
| 8 | Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomasbreakdown → | 2017 | 1266 |
| 9 | 2016 | 165 | |
| 10 | 2014 | 181 | |
| 11 | 2014 | 220 | |
| 12 | 2013 | 358 | |
| 13 | 2005 | 2 | |
| 14 | 2004 | 59 | |
| 15 | 2004 | 10 | |
| 16 | 2003 | 123 | |
| 17 | 2002 | 10 | |
| 18 | 2002 | 112 | |
| 19 | 2002 | 154 | |
| 20 | A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1. | 1998 | 24 |
About Jennifer L. Brogdon
Jennifer L. Brogdon is a scholar working on Immunology, Oncology and Toxicology, having authored 30 papers that have together received 3.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Signaling Pathways in Disease (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (2.1k citations) and Genetics (418 citations). Jennifer L. Brogdon has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Kim Bottomly, Deborah Knee, Glenn Dranoff, Simon F. Lacey, J. Joseph Melenhorst, Carl H. June, Bruce L. Levine, David L. Porter, Sunita D. Nasta and Stephen J. Schuster. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.